Who Should Read This Article?
- Researchers, university administrators, and science policy professionals interested in the history, organizational structure, and distinctive characteristics of the Howard Hughes Medical Institute (HHMI).
- Scientists and research managers seeking to understand alternative funding models that support scientific creativity and long-term research.
- Readers interested in how private wealth can be transformed into sustainable financial support for scientific research and the development of future generations of scientists.
Summary
- The Howard Hughes Medical Institute (HHMI) is one of the world's leading private biomedical research institutions, established in 1953 by American industrialist Howard Hughes.
- In 1985, HHMI sold Hughes Aircraft Company, establishing an endowment of approximately $5.2 billion and transforming itself from an organization dependent on corporate earnings into one supported by a diversified investment portfolio.
- Its defining philosophy is “People, not projects,” emphasizing long-term, flexible support for exceptional scientists rather than funding narrowly defined research proposals.
- Today, HHMI operates a comprehensive research ecosystem encompassing university-based investigators, an independent research campus, early-career scientist development, science education, and open science.
- HHMI's history illustrates the importance of integrating sustainable financing, rigorous researcher selection, scientific independence, and research evaluation into a coherent institutional model.
1. What Is the Howard Hughes Medical Institute (HHMI)?
The Howard Hughes Medical Institute (HHMI) is one of the world's leading private biomedical research institutions. It was established in 1953 by Howard Hughes, an American industrialist and aviation pioneer.
Its defining characteristic is a philosophy often summarized as “People, not projects.”
Rather than primarily supporting predetermined research proposals, HHMI invests in exceptional scientists by providing long-term funding, scientific freedom, and stable research environments.
This approach enables researchers to pursue original, ambitious, and potentially transformative basic research that may be difficult to undertake through conventional funding mechanisms focused on short-term deliverables.[1][5]
Three major turning points are particularly important for understanding HHMI's history.
| Year | Major Event | Significance |
|---|---|---|
| 1953 | Establishment as a medical research institution owning an aircraft company | Howard Hughes transferred shares of Hughes Aircraft Company to HHMI, creating a mechanism through which corporate earnings could support medical research. |
| 1985 | Sale of Hughes Aircraft Company | The sale to General Motors established an endowment of approximately $5.2 billion, transforming HHMI from an institution dependent on corporate earnings into one supported by investments in financial assets. |
| 2006 | Opening of Janelia Research Campus | HHMI expanded beyond supporting scientists at universities by developing and operating its own research campus. |
Through these transformations, HHMI evolved into an unusual type of organization that combines the functions of a scientific research institution and a privately funded research-support organization.
It is neither simply a grant-making foundation nor a conventional university research institute.[2][3]
2. How Was HHMI Established?
2.1 Who Was Howard Hughes?
Howard Hughes (Howard R. Hughes Jr., 1905–1976) was an American industrialist who accumulated enormous wealth through aircraft development, filmmaking, corporate management, and aviation-related businesses.
One of his companies, Hughes Aircraft Company, became a major enterprise specializing in electronics, aerospace technology, and defense-related systems.
On December 17, 1953, Hughes established HHMI as a nonprofit corporation under Delaware law.
The institution's stated purpose was to advance knowledge in basic science, particularly through medical research and medical education, for the benefit of humanity.
This mission was explicitly described in the organization's founding charter.[2]
2.2 The Financial Structure Behind HHMI's Establishment
HHMI's establishment differed from a conventional charitable donation by a wealthy individual.
Hughes reorganized his aerospace-related business interests and donated all the shares of Hughes Aircraft Company to HHMI.
As a result, HHMI became a nonprofit medical research institution that owned 100% of an aerospace and defense company.
The original ownership and financial structure can be summarized as follows.
| Entity | Role |
|---|---|
| Howard Hughes | Founder and sole trustee of HHMI. He donated the shares of Hughes Aircraft Company. |
| HHMI | A nonprofit medical research institution that owned all shares of Hughes Aircraft Company. |
| Hughes Aircraft Company | An aerospace and defense-related company whose earnings provided financial support for HHMI's research activities. |
This arrangement had two important dimensions.
First, it provided a mechanism for continuously directing earnings from an aerospace business toward medical research.
Second, transferring the company's shares to a nonprofit corporation significantly altered the tax treatment of those assets and related activities.
The circumstances surrounding HHMI's creation suggest that the arrangement involved not only philanthropic objectives but also considerations related to corporate control and tax strategy.
However, it would be inappropriate to attribute Hughes's personal motivations to any single explanation.
The institutional ownership structure and financial arrangements were documented in detail in a 1984 decision by the Delaware Court of Chancery.[2]
2.3 HHMI's Early Research Activities Were Relatively Limited
Although HHMI owned substantial corporate assets from its establishment, its medical research activities during the 1950s through the 1970s were relatively limited compared with its present operations.
Beginning in the late 1950s, the institution gradually established research units at universities and hospitals, developing systems to employ and support scientists.
Its status as a nonprofit organization also attracted attention from tax authorities.
A central issue was whether an organization that owned an aerospace company was genuinely operating as a charitable medical research institution.
In 1957, the U.S. Internal Revenue Service (IRS) recognized HHMI's tax-exempt status.[2]
3. Major Turning Points in HHMI's Development
3.1 1976–1984: Howard Hughes's Death and the Reorganization of Governance
Howard Hughes died on April 5, 1976.
Although he had served as HHMI's sole trustee, he had not clearly designated a successor.
Consequently, disputes emerged between individuals involved in managing the institution and those responsible for Hughes's estate over who held legal authority to govern HHMI.
These disputes were addressed in Delaware courts.
In 1984, HHMI underwent a significant transition toward a new board governance structure.
This development marked HHMI's transformation from an organization dependent on the personal control of its founder into an independent institution governed by a board responsible for long-term research strategy and asset management.[2]
3.2 1985: The Sale of Hughes Aircraft and HHMI's Transformation
The year 1985 marked the most important financial turning point in HHMI's history.
That year, HHMI sold Hughes Aircraft Company to General Motors.
The transaction established an endowment of approximately $5.2 billion.
This figure represents the amount at the time of the transaction in 1985, not an inflation-adjusted value.[3]
The sale fundamentally changed HHMI's financial model.
Previously, its financial foundation depended on the performance of a particular aerospace company.
Following the sale, the institution could generate funding for scientific research by managing a diversified portfolio of financial assets over the long term.
This transformation facilitated the expansion of its scientific workforce, large-scale investments in biomedical research, and the establishment of new science education programs.
During the presidency of Purnell W. Choppin, who led HHMI from 1987 to 1999, the number of HHMI Investigators more than tripled, and the institution's science education grant-making activities expanded substantially.[3]
3.3 2006: The Opening of Janelia Research Campus
In 2006, HHMI opened Janelia Research Campus, its own research facility in Ashburn, Virginia.
This development represented an expansion beyond HHMI's traditional model of supporting investigators working at universities.
Under the Janelia model, HHMI could directly design research facilities, organize scientific teams, and create research environments aligned with its institutional philosophy.
Janelia emphasizes small research groups, interdisciplinary collaboration, and the pursuit of ambitious scientific problems that may require long-term investigation.
Its original scientific focus included several areas:
- Understanding the principles of information processing in neural circuits
- Developing advanced imaging technologies
- Creating computational methods for image analysis
This research environment represents a distinctive approach to advancing basic science, complementing HHMI's university-based investigator programs.[1]
4. HHMI's Current Scale and Financial Foundation
According to HHMI's audited financial statements for the fiscal year ended August 31, 2025, the institution held approximately $27.6 billion in net assets.
This represents an exceptionally large financial foundation for a private biomedical research institution.
4.1 Key Financial Figures for Fiscal Year 2025
| Financial Metric | FY2025 Amount |
|---|---|
| Net assets | $27.62 billion |
| Investments and derivative assets | $27.34 billion |
| Annual medical research expenses | $847 million |
| Total annual expenses | $1.046 billion |
| Net investment return | Approximately $3.08 billion |
These figures are based on HHMI's audited financial statements for fiscal year 2025.[4]
It is important to distinguish between net assets and investment assets.
Net assets represent total assets minus liabilities, whereas investment assets refer to a specific category of financial holdings.
4.2 HHMI's Expenditure Structure in FY2025
HHMI's expenditures for fiscal year 2025 can be summarized as follows.
| Category | Expenditure |
|---|---|
| Medical research | Approximately $846.5 million |
| Science education, fellowships, and related activities | Approximately $66.1 million |
| Administration and other expenses | Approximately $133.9 million |
These amounts are based on the expense categories presented in HHMI's audited financial statements.[4]
Three aspects of this expenditure structure deserve particular attention.
First, HHMI spends approximately $850 million annually on medical research.
Rather than concentrating its resources on a single scientific topic, it continuously supports numerous investigators and research facilities.
Second, its research activities are financed primarily through the management of a large portfolio of financial investments.
In FY2025, HHMI reported approximately $3.08 billion in net investment returns.
However, investment returns include gains and losses arising from changes in market valuations.
Therefore, this figure should not be interpreted as a guaranteed amount of annual cash income.
Third, HHMI also invests substantially in science education and researcher development.
Its FY2025 financial statements reported approximately $66.08 million in expenses associated with science education, fellowships, and media-related activities.
This demonstrates that HHMI's mission extends beyond conducting biomedical research to include developing future generations of scientists and creating educational resources.[4]
5. HHMI's Defining Feature: Long-Term Investment in Scientists
5.1 The Philosophy of “People, Not Projects”
The philosophy of “People, not projects” lies at the center of HHMI's research-support model.
The fundamental idea is to invest in the abilities and future potential of exceptional scientists rather than exclusively funding specific research proposals.
Under conventional competitive grant systems, researchers generally submit detailed proposals describing their research questions, experimental plans, budgets, and expected results.
Once funding is awarded, researchers are typically expected to carry out the approved projects within a predetermined period.
HHMI takes a different approach.
It selects outstanding investigators and provides them with long-term, flexible support that allows them to pursue promising scientific directions.
The principal differences can be summarized as follows.
| Dimension | Conventional Project-Based Research Grants | HHMI Investigator Program |
|---|---|---|
| Primary focus | Research projects and proposals | Individual scientists and their research potential |
| Funding duration | Varies by program | Generally seven years, renewable |
| Research direction | Primarily based on the approved proposal | Can evolve flexibly in response to new discoveries |
| Employment relationship | Researchers are generally employed by their universities or institutions | Researchers are directly employed by HHMI |
| Evaluation | Project progress and research outcomes | Scientific achievements and future potential |
| Funding structure | Budget tied to the approved project | Salary, research funding, equipment support, and related resources |
This comparison illustrates representative institutional differences. Some conventional grant programs also provide long-term and flexible funding.[5]
The significance of HHMI's approach becomes particularly apparent in basic scientific research.
Important discoveries do not always emerge according to predetermined research plans.
Unexpected experimental results may reveal entirely new scientific questions, sometimes leading researchers in directions very different from those originally proposed.
HHMI's system is designed to accommodate such developments by allowing changes in research direction, extended experimentation, and the pursuit of challenging hypotheses.
However, scientific independence does not mean an absence of accountability.
Investigators undergo rigorous selection before appointment and scientific evaluation when their appointments are considered for renewal.
The essential feature of HHMI's model is its combination of rigorous talent selection and substantial scientific freedom after appointment.
5.2 Combining University Affiliation with HHMI Employment
HHMI Investigators maintain laboratories at universities while being employed by HHMI.
The typical institutional arrangement involves the following responsibilities.
| Entity | Primary Responsibilities |
|---|---|
| HHMI | Researcher employment, salaries, research budgets, and equipment support |
| HHMI Investigator | Defining research directions, conducting research, and managing research groups |
| University or research institution | Providing laboratory space, academic affiliation, research infrastructure, and scholarly communities |
This arrangement operates through collaborative agreements between HHMI and the host institutions.[5]
In effect, HHMI has established a distributed network of researchers across universities in the United States.
Investigators can benefit from their universities' intellectual environments and research infrastructure while receiving long-term support from HHMI.
At the same time, universities benefit from having exceptional scientists whose research activities are strengthened by external institutional support.
This is an interesting organizational model because the university provides much of the physical and academic infrastructure, while a separate institution assumes responsibility for supporting and employing the investigators.
5.3 Small, Interdisciplinary Research Groups at Janelia
In addition to its distributed university-based investigator program, HHMI uses a different organizational approach at Janelia Research Campus.
From its establishment, Janelia emphasized relatively small research groups led by scientists who remain actively involved in experimental and scientific work.
Biologists, physicists, mathematicians, computational scientists, and engineers collaborate closely to address difficult biological problems.
Their work often involves developing new measurement instruments and analytical methods specifically designed to answer scientific questions.
This differs from an organizational structure consisting primarily of numerous large laboratories separated by research discipline or topic.[1]
6. HHMI's Major Research and Scientist Development Programs
HHMI supports scientists at multiple stages of their careers, from doctoral studies and postdoctoral training to early independence and established research leadership.
6.1 HHMI Investigators
The HHMI Investigator Program is the institution's central research-support initiative for outstanding mid-career and senior scientists.
Investigators receive renewable appointments, generally lasting seven years, together with salaries, research funding, and equipment support.
They remain academically affiliated with their universities while being employed by HHMI.
This arrangement allows them to pursue research from a long-term perspective.[5]
6.2 Freeman Hrabowski Scholars
The Freeman Hrabowski Scholars Program was launched in 2022 to support promising early-career independent scientists.
The program generally provides five years of support, with the possibility of extending support to a maximum of ten years following review.
In 2026, HHMI expanded the scope of the program and began integrating its support framework to include researchers at the postdoctoral stage.[1]
6.3 Hanna H. Gray Fellows
The Hanna H. Gray Fellows Program supports scientists transitioning from postdoctoral positions to independent research careers.
Beginning in 2026, its selection and support framework has been transitioning toward integration with the Freeman Hrabowski Scholars Program.[1]
6.4 Gilliam Fellows
The Gilliam Fellows Program supports the development of doctoral researchers.
In addition to scientific research capabilities, the program emphasizes mentoring, effective supervision, and the creation of supportive research environments.[1]
Together, these programs reflect an institutional strategy that goes beyond providing temporary research grants.
HHMI seeks to support the development of scientists throughout their careers, from early training to independence and established research leadership.
However, HHMI programs have specific eligibility and institutional requirements.
They are not universally open to scientists from every country.
The institution's major investigator employment programs are primarily based at eligible research institutions in the United States.[1][5]
7. HHMI's Scientific Achievements and Broader Impact
HHMI's significance extends beyond the large amounts of money it allocates to research.
A central part of its contribution has been the creation of conditions that enable fundamental biological discoveries and the development of new scientific technologies.
One illustration of its impact is the recognition of HHMI-supported scientists through Nobel Prizes.
7.1 Jennifer Doudna: 2020 Nobel Prize in Chemistry
Jennifer Doudna received the 2020 Nobel Prize in Chemistry.
Her Nobel-recognized work involved the development of CRISPR-Cas9 genome-editing technology.
This technology has had a profound impact on genetics, biomedical research, and biotechnology.
7.2 Carolyn Bertozzi: 2022 Nobel Prize in Chemistry
Carolyn Bertozzi received the 2022 Nobel Prize in Chemistry.
Her research contributed to the development of bioorthogonal chemistry, which enables chemical reactions to take place within living systems without disrupting surrounding biological processes.
7.3 David Baker: 2024 Nobel Prize in Chemistry
David Baker received the 2024 Nobel Prize in Chemistry for his contributions to computational protein design.
His research represents an important example of the integration of computational approaches with biological science.
According to HHMI, more than 30 scientists supported by the institution have received Nobel Prizes since 1978.[1]
However, these achievements should not be attributed exclusively to HHMI's support.
Universities, collaborators, public research funding agencies, and other institutions also contributed to the scientific work underlying these discoveries.
8. Lessons from HHMI's Organizational Model
HHMI's achievements cannot be explained solely by the scale of its financial assets.
An equally important factor is the institutional design through which those assets are converted into sustained scientific activity.
The organization's major structural characteristics and their potential effects can be summarized as follows.
| Organizational Characteristic | Potential Benefits for Research |
|---|---|
| Large, long-term investment portfolio | Reduces dependence on annual budgets and enables sustained support for scientific research. |
| Investment in individual scientists | Makes it easier to change research directions and pursue unexpected discoveries. |
| Rigorous investigator selection | Helps balance substantial scientific freedom with high standards of research quality. |
| Distributed collaboration with universities | Allows HHMI to utilize existing university research infrastructure without independently constructing every laboratory. |
| Independent research campus | Enables the design of collaborative research environments that are not constrained by conventional university organizational structures. |
| Continuous support for early-career researchers | Integrates the development of future scientists into the institution's long-term research strategy. |
| Open science | Encourages the sharing of scientific findings, data, and technologies. |
However, this model also presents challenges.
Because scientists are selected through highly competitive processes, the number of researchers who can receive sustained support is limited.
The institution's long-term sustainability also depends on investment performance, responsible expenditure management, and effective mechanisms for evaluating scientific achievements.
Consequently, providing substantial financial resources alone would not necessarily reproduce HHMI's achievements in another country or research institution.
What matters is the integrated design of long-term financing, investigator selection, scientific autonomy, and research evaluation.
9. What Can We Learn from HHMI's History?
HHMI's development over more than seven decades can be divided into five broad phases.
9.1 1953–1976: Establishing a Medical Research Institution Through Corporate Assets
During this period, a wealthy industrialist established a medical research institution using shares in a company he owned.
A distinctive financial structure emerged in which earnings from an aerospace business were directed toward medical research.
9.2 1976–1985: Reorganizing Governance and the Financial Structure
Following the death of its founder, HHMI restructured its governance and asset ownership arrangements.
The transition to a board-led governance system and the sale of the aerospace company shaped the institution's subsequent development.
9.3 1985–2000: Expanding Support for Scientists
With a substantial endowment, HHMI significantly expanded its support for scientific research.
Its researcher employment and support systems grew, and its science education grant-making activities developed.
9.4 The 2000s Onward: Combining University-Based Research with an Independent Campus
HHMI began integrating its distributed university-based research model with an independently operated research campus.
The opening of Janelia Research Campus in 2006 marked its evolution from an organization primarily supporting scientists to one that also directly designs research environments.
9.5 Today: Comprehensive Support for Basic Research and Scientist Development
Today, HHMI supports basic scientific research, researcher development, open science, and science education.
By combining university partnerships, independent research facilities, and early-career development programs, the institution sustains a broad ecosystem for long-term scientific research.
9.6 Overall Assessment
One of the most remarkable aspects of HHMI's history is the transformation of wealth generated by the aerospace industry into an institutional mechanism capable of supporting biomedical research long after its founder's death.
Over time, HHMI evolved beyond the idea of simply providing money for scientific research.
Instead, it increasingly focused on creating environments in which exceptional scientists could pursue their research with intellectual freedom.
The fundamental significance of HHMI lies in its establishment of a system that uses private financial assets to invest in the long-term creativity and potential of individual scientists.
Its history provides an important example of how large-scale private wealth can be directed toward sustained investments in scientists and research environments rather than narrowly defined short-term research outcomes.
For this reason, HHMI offers valuable lessons for those involved in science and technology policy, research funding, and the management of scientific institutions.
References
[1] Howard Hughes Medical Institute, “About HHMI,” HHMI Official Website. https://www.hhmi.org/about
[2] Delaware Court of Chancery, “Oberly v. Howard Hughes Medical Institute,” 472 A.2d 366, 1984. https://law.justia.com/cases/delaware/court-of-chancery/1984/472-a-2d-366-4.html
[3] Howard Hughes Medical Institute, “In Memoriam: Purnell W. Choppin, Former President of HHMI,” HHMI News. https://www.hhmi.org/news/memoriam-purnell-w-choppin-former-president-hhmi
[4] Howard Hughes Medical Institute, “FY 2025 HHMI Audited Financial Statements,” 2025. https://www.hhmi.org/sites/default/files/2025-11/FY-2025-HHMI-Audited-Financial-Statements.pdf
[5] Howard Hughes Medical Institute, “HHMI Investigator Program,” HHMI Official Website. https://www.hhmi.org/programs/investigators
[6] Howard Hughes Medical Institute, “Research Policies,” HHMI Official Website. https://www.hhmi.org/about/policies